Cargando…
Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of Immunotherapy
Autores principales: | Raez, Luis E., Cardona, Andrés F., Arrieta, Oscar, Lopes, Gilberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328112/ https://www.ncbi.nlm.nih.gov/pubmed/32511065 http://dx.doi.org/10.1200/GO.20.00004 |
Ejemplares similares
-
Blood cancer health disparities in the United States Hispanic population
por: Bencomo-Alvarez, Alfonso E., et al.
Publicado: (2021) -
Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer
por: Soberanis Pina, Pamela, et al.
Publicado: (2023) -
BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutations
por: Cardona, Andrés F., et al.
Publicado: (2016) -
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP)
por: Raez, Luis E., et al.
Publicado: (2022) -
Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression
por: Cardona, Andrés Felipe, et al.
Publicado: (2016)